Table 1.
Main features of the population.
| Patients with FMF and Amyloid Goiter | |
|---|---|
| Males (n = 42), n (%) | 24 (57) |
| Ethnicity (n = 42) | |
| Turkey (n) | 23 |
| Israel (n) | 5 |
| Iran (n) | 1 |
| Georgia (n) | 1 |
| Armenia (n) | 1 |
| Unknow (n) | 11 |
| Disease characteristics | |
| Age at diagnosis of FMF (n = 28), median (IQR) | 10 (8.75–24.75) |
| Age at amyloidosis diagnosis (n = 26), median (IQR) | 23.5 (15.25–36.75) |
| Renal failure (n = 35), n (%) | 34 (97.10) |
| Hemodialysis (n = 31), n (%) | 28 (90) |
| Kidney transplant (n = 32), n (%) | 9 (28) |
| Goiter characteristics | |
| Age at diagnosis of goiter (n = 34), median (IQR) | 30 (23–45) |
| Symptoms (n = 29) | |
| Asymptomatic, n (%) | 8 (27) |
| Dyspnea, n (%) | 17 (58) |
| Dysphagia, n (%) | 13 (44.8) |
| Dyspnea and dysphagia, n (%) | 9 (31) |
| Pain, n (%) | 2 (6.8) |
| Unknow, n | 13 |
| Thyroid function (n = 37) | |
| Euthyroidism, n (%) | 28 (75.6) |
| Hypothyroidism, n (%) | 2 (5.4) |
| Subclinical hypothyroidism, n (%) | 4 (10.8) |
| Hyperthyroidism, n (%) | 2 (5.4) |
| Dysthyroidism with no precision, n (%) | 1 (2.7) |